CELONIC Group products

An extremely productive and stable CHO-based expression system for biopharmaceuticals. CHOvolution® is a CHO-K1 based expression platform that can be used for a broad range of applications, from non-GMP R&D testing to GMP development and commercial market supply, with a support system to help throughout every step of development. Besides offering cell line development services, Celonic is selling and outlicensing the system to other service providers and drug developers.

Our human GEX® platform is the best choice when working with defucosylated antibodies, complex molecules or glycosylated proteins. GEX® technology allows the optimization of glycosylation to improve critical quality attributes for better clinical performance, such as potency, bioavailability, stability and/or immunogenicity. This technology is based on a human cell line family optimized for both product quality optimization and fast, highly reproducible, high yield glycoprotein manufacturing. An established continuous biomanufacturing process provides homogenous and stable glycosylation patterns and overall consistent batch-to-batch product quality.